NLPB COVID-19 Guidance for Pharmacy Professionals

Registrants are reminded that since March of last year, NLPB has maintained a guidance page specific to COVID-19 at https://nlpb.ca/covid-19-guidance-for-pharmacy-professionals/. This page is regularly reviewed and updated to provide pharmacy professionals with information and advice specific to the pandemic.

Recently, the page was updated to add information related to COVID-19 vaccines, the recommendations for their use, and their safety:

Registrants are asked to review the COVID-19 Guidance for Pharmacy Professionals page regularly to stay informed, as the situation continues to evolve.


Patient Counselling – Changes in Drug Therapy

Recently, the NLPB office was contacted by a physician who was concerned that his patient had not received some vital information from a pharmacist in relation to a recent medication dosage change. The patient had been previously prescribed 25mg of a medication in the morning and 50 mg in the evening. Since the medication was dispensed as 25mg capsules, she was taking one capsule in the AM and two capsules PM. After a period, the patient’s dose was increased to 50mg BID and subsequently dispensed as 50mg capsules. However, the patient was not counselled as to the change and continued to take according to the previous schedule, resulting in her receiving 50 mg in the morning, but 100 mg in the evening.

Pharmacists are reminded that patient counselling is a basic expectation of the standards of practice and that particular attention should be paid to changes in drug therapy such as dosage or regimen changes, as these are at higher risk for patient misinterpretation and medication errors.


Tips to Ensure Applications Are Processed in a Timely Manner

NLPB receives many applications over the course of a week. Unfortunately, a number of these applications are often illegible, incomplete, or missing supporting documentation or payment requiring office staff to contact the registrant, causing a delay in processing and approving the application. In order to ensure that your application is processed in a timely manner, please take a moment before submission to ensure that all fields are completed and legible, and that all supporting documentation is included. These small steps will help improve the process for both the applicant and NLPB.


SaferMedsNL / Quality of Care NL Interprofessional Session

SaferMedsNL, in partnership with Quality of Care NL, is hosting a free interprofessional session for prescribers and pharmacists in Newfoundland and Labrador to discuss the appropriate use of proton pump inhibitors and sedative-hypnotics for insomnia.

Details:
Thursday, January 28, 2021
7:00-8:30 PM (NST)

The session, presented virtually via Zoom, will focus on:

  • the evidence behind deprescribing these medications,
  • the tools and resources available to support health care providers,
  • recommending safer, more effective alternatives,
  • ongoing work in the province, supported by available data, to promote the appropriate use of these medications.

 
Speakers include:

  • Dr. Barbara Farrell – University of Ottawa
  • Dr. David Gardner – Dalhousie University
  • Dr. Justin Turner – SaferMedsNL
  • Dr. Kimberly Wintemute – Choosing Wisely Canada
  • Dr. Robert Wilson – Quality of Care NL

 
To register, visit https://us02web.zoom.us/webinar/register/WN_b7riYcyeTLej-bUyrePOUg.


Opioid Dependence Treatment Centre of Excellence- Project ECHO NL Sessions

Project ECHO NL: Opioid Use Disorder is a virtual community advancing care and treatment for opioid use disorder in Newfoundland and Labrador. This project offers free, virtual learning sessions using an interactive, web-based platform (Zoom) to link health care providers with a consistent, core interdisciplinary team of mentors with expertise in managing substance use care. The primary audience is prescribers (family physicians and nurse practitioners) and pharmacists.

Session 4: Opioid Agonist Treatment (OAT) and Pharmacy (Introductory)Flyer

Session 5: Trauma-Informed Care and Psychosocial Supports (Introductory)Flyer

For more information about Project ECHO NL: Opioid Use Disorder, including frequently asked questions, please visit their website at: https://mha.easternhealth.ca/adults/opioid-treatment-and-naloxone/echo/


Regular reminders

  • Registrant Contact Information – Registrants are responsible for ensuring that the contact information on their registrant profile, including email address and practice site, is accurate at all times. The NLPB primarily uses email communication to send newsletters, renewal reminders, practice site assessment information, professional development audit information, calls for interest for committees, and other alerts. If the email address on file is incorrect, important information may be missed and/or disclosed to the wrong person. If your contact information changes, please log into the NLPB Online Registrant Portal to update your file with your new contact information as soon as you can.
  •  

  • Forgot Your Password? – You can retrieve your NLPB Online Registrant Portal password at any time. Under the Login box, click the message that says, “Forgot your password? Click here to restore it.” On the next screen, enter your NLPB username, if you know it, or your email address. Click “Retrieve.” In a few minutes, you will receive an email with your username and password. Once you are logged into your profile, you can change your password.
  •  

  • Receipts & Invoices – NLPB’s Online Registrant Portal maintains all receipts created by the system. If for any reason, you need a receipt or to view an invoice, you can do so from your registrant profile. Once logged in, click on “Renewal Other/Invoices” and then select either “view invoice” or “print invoice” next to the one you are interested in.

This e-newsletter contains information on a wide variety of topics intended to enhance the practice of pharmacy in the province of Newfoundland and Labrador. As it is published and circulated to all registrants on a monthly basis, it is the expectation of NLPB that all registrants are aware of the matters contained therein.



©2021 Newfoundland & Labrador Pharmacy Board